According to the authors, Lnc-LSG1 can bind directly to the ESRP2 protein resulting in ubiquitin-proteasome pathway-mediated inhibition of its expression, which translates into the stimulation of ccRCC metastasis. Here, ESRP2 is linked to nonpapillary renal cell carcinoma.